Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector
- Supplementary File 1:
ZIP-Document (ZIP, 279 KiB)
Maurer, L.; El Andari, J.; Rapti, K.; Spreyer, L.; Steinmann, E.; Grimm, D.; Dao Thi, V.L. Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector. Viruses 2022, 14, 266. https://doi.org/10.3390/v14020266
Maurer L, El Andari J, Rapti K, Spreyer L, Steinmann E, Grimm D, Dao Thi VL. Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector. Viruses. 2022; 14(2):266. https://doi.org/10.3390/v14020266
Chicago/Turabian StyleMaurer, Lars, Jihad El Andari, Kleopatra Rapti, Laura Spreyer, Eike Steinmann, Dirk Grimm, and Viet L. Dao Thi. 2022. "Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector" Viruses 14, no. 2: 266. https://doi.org/10.3390/v14020266